20
Cleared, 88PA, Case # 2018-0587, 8 Feb 2018 1 Air Force 711 th Human Performance Wing – Application of NAMs Prepared by Laura Stolle, PhD, Lead Research Toxicologist Presented by Lisa Sweeney, Ph.D., Risk Assessment Toxicologist at UES, Inc. May 23, 2019

Air Force 711 Human Performance Wing –Application of NAMs · 2018-02-08  · Cleared, 88PA, Case # 2018-0587, 8 Feb 2018 1 Air Force 711th Human Performance Wing –Application

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 20181

    Air Force 711th Human Performance Wing – Application

    of NAMsP r e p a r e d b y L a u r a S t o l l e , P h D , L e a d R e s e a r c h To x i c o l o g i s t

    P r e s e n t e d b y L i s a S w e e n e y, P h . D . , R i s k A s s e s s m e n t To x i c o l o g i s t a t U E S , I n c .

    M a y 2 3 , 2 0 1 9

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 20182

    Total Exposure Health – Big Picture

    AFMS CONOPS to enable capture of workplace,

    environmental, and lifestyle exposures experienced by an individual to prevent disease

    • Emphasis is to leverage and advance:• Exposure Science• Sensor & data technologies• Health informatics• Clinical support systems

    • Goals are to:• Obtain holistic health status• ID root causes of disease/injury• Provide innovative, accessible

    methods for primary prevention

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 20183

    Systems Biology for Performance VisionElucidate warfighter biologic state and the underlying mechanism of responses such that we can build a computational model/"virtual warfighter" that recapitulates warfighter physiology in diverse operational environments

    Enabling individual variable responses to any operational stressor/perturbation (hypoxia, hyperoxia, stress, fatigue, flight line operations, thermal stress, directed energy) to be predicted

    From Institute for Systems Biology

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 20184

    In Vitro to In Vivo Extrapolation

  • Cleared, 88PA, Case # 201x-xxxx, xx Mon 201x.5

    In Vitro Data Production

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 20186

    In Vitro – human stem cells

    Marchetto and Gage 2010

    MAP2 (neuron); GFAP (astrocyte); DAPI (nuclei)

    In collaboration with Anne Bang at Sanford Burnham Prebys

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 201877

    Airman-on-a-Chip: Gut-Microbiome-Brain Axis Work-Flow

    Operational Stressors

    Fatigue Sleep deprivation Oxygen content

    Environmental Stressors

    Extreme temperatures High elevation Bacteria / viruses

    Gut – Microbiome – Brain Axis Organ Systems: Homeostasis, Dysbiosis, Countermeasure Development

    3D Extracellular Matrix

    Cells: Gut/Endo./iPSC

    GUT

    Endothelium

    GUT Tissue

    Jenkins et al. Nutrients 2016, 8(1), 56; https://doi.org/10.3390/nu8010056

    Microfluidic Device

    Shear Stress + Mechanical Forces

    CognitionAwareness

    PerformanceMetabolism

    Homeostasis

    Barrier Integrity

    Tyler Nelson

  • Gut-Organ Axis Discovery/Evaluation

    Cleared, 88PA, Case # 2018-0587, 8 Feb 2018

    Syn-Bio Chassis and/or Gut Microbiota

    Target Cells

    Gut Epithelial CellsDirect

    Perfusion and

    Transport

    Secreted Microbiota Signal Molecules

    Microbiota & Host Signal Molecules

    Bacteria – Host Cell Contact for Signal Transfer

    Scan of Bacterial-Host-Target Using Monoculture and Complex Bacterial

    Population

    Permeable Membrane

    Microbiome Surface & Excreted Signal Analyses

    Platform Use: SynBio Engineered Chassis Single Bacterial Component (Monoculture) Single Bacterial Component + Mock Community Cecum/Fecal Full Microbiome

    Microbiome (MB): Culture & Biofilm (= MAM)16S rRNA Sequencing – Population DynamicsqPCR quantitation of specific speciesMeta transcriptomicsMeta proteomics

    MB Output Molecules: Metabolomics – bacterial excreted metabolitesLipidomics – SCFA fatty acid chains

    Gut Epithelial (GE) Response: TranscriptomicsTargeted qRT-PCRCytokinesMALDI Imaging for global Omic AnalysisMAFFs

    MB/GE Output Molecules: MetabolomicsLipidomicsProteomics - neuropeptides

    Target Cell (TC): TranscriptomicsqRT-PCR Key Pathway Genes

    TC (Neuronal): Metabolomics, Lipidomics, Proteomics

    TC (Skeletal Muscle): Metabolomics, Lipidomics, ProteomicsMarkers of Damage, Energy MetabolismContractionCamilla Mauzy

    8

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 20189

    Modeling Performance Enhancement/Protection-tDCS Using Human Mini Brains

    Q: What molecular changes are initiated by direct current stimulation?

    (4 different neuronal classes + oligodendrocytes + astrocytes)

    Pathways of Interest: Angiogenesis, Neurogenesis, Synaptic PlasticityLaura Stolle

  • In Vitro – Personalized Risk

    Cleared, 88PA, Case # 2018-0

    Patrick McLendon

    Chemical exposure

    Nuclear Envelope Determination

    Cytoplasmic Volume

    Nuclear Area / Cell Area

    Phenotypic IDPhenotypic features that characterize response of cells to chemicals

    ID correlation between genetic makeup and differential phenotypic responses

    •Toxin sensitivity•Disease susceptibility•Therapeutic response•Therapeutic optimization

    predict

    correlate

    sensitive

    resistant

    HCA features

    Chemical “X”concentration

    Commercially availablegenetically defined cells

    A B C

    ABC

    A B C

    587, 8 Feb 201810

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 201811

    Assessment of Neuro-Vascular Responses to HyperoxicOscillations in Airman: A Systems Biology Approach

    Tyler Nelson

  • Cleared, 88PA, Case # 201x-xxxx, xx Mon 201x.12

    Biological Systems Modeling

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 201813

    Development of a Generalized Inhalation Model for Use with the High-Throughput Toxicokinetics (httk) Package in R

    Dr. Matt Linakis- Recent collaborative workwith the USEPA

    • 42 chemicals for model building/training

    • Input: • Gas inhalation

    • Output: • Blood and other tissue

    concentrations• Exhaled breath

    concentrations

    • Under Development:• Aerosol inhalation

    Lung TissueLung Blood

    Alveolar Space

    Gut TissueGut Blood

    Gut Lumen

    Liver TissueLiver Blood

    Body TissueBody Blood

    Kidney TissueKidney Blood

    Qcardiac

    Arterial Blood

    Qkidney

    Qrest

    Qliver

    Qgut

    Veno

    us B

    lood

    Qalv Qalv

    Inhaled Air

    kgutabs

    Clmetabolism

    Qgfr

    Exhaled Breath

    (MM Elim)

    Mucous

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 201814

    The Potential for Genetic Variation to Impact Risk Estimates from Chemical Exposures in a United States Air Force Population

    Brain

    Alveolar

    Fat

    Rapid

    Slow

    urine

    Liver

    Art

    eria

    l Blo

    od

    Veno

    us B

    lood

    inhaleddose

    URT Mucus

    metabolism

    Jeffery Gearhart and Joseph Jarvis

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 201815

    Development of Exposure Limits for Chemicals Encountered During Aircraft Operation

    Drs. Lisa Sweeney, Matt Linakis

    Aircrew Problem Formulation—In-flight airborne chemicalcontaminants

    Population: healthy adults Exposure

    • Assume 2 flights (1 h/flight) per day with 2 hseparation on three consecutive days

    • Several stressors possible (heat, exertion, altitude,+Gz forces, vibration)

    Comparator• Same exposure concentration and schedule, lack

    of stressors (modified value) Outcome

    • Critical effect(s) for toxicity reference valuederivation

    Exposure: 25 ppm 1,2,4-Trimethylbenzene (TMB)

    Predicted peak bloodconcentrations of 1,2,4-TMB are ~5-fold higherunder physiologicalstress (heart rate = 120bpm) vs. baseline.

    Impact of the flight-related stressors +Gz forces and altitude/barometric pressure on physiologically-based pharmacokinetic model parameters used for risk assessment

    • ~170 articles reviewed, data extracted from ~70.

    • >20 data synthesis figures have been prepared (see example below)

    Fractional change in cerebral blood flow velocity due to increases in +Gz (baseline of +1 Gz). ○: Kawai et al. 1997; ×: Ossard et al. 1994, 1996; �: other sources (Iwasaki et al. 2012, Ogawa et al. 2016, Stevenson and Scott 2014). Trendline: y = 0.0083 x2 –0.1505 x; r2 = 0.805

    Current efforts:

    Incorporate stressor-related impacts into physiologically based pharmacokinetic models

    Literature review/data extraction for vibration

  • Cleared, 88PA, Case # 201x-xxxx, xx Mon 201x.16

    In Vivo Validation

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 201817

    In Vivo Validation

    + =

    Low level exposure operational features of flight• G-forces• Oxygenation• Argon (and other air components)• Hypobaric pressure• Isometric workload• Work of breathing

    ?

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 201818

  • Cleared, 88PA, Case # 2018-0587, 8 Feb 201819

    Acknowledgements• Dr. Heather Pangburn, RHB, Systems Biology for Performance Core Research Area Lead

    • Dr. Darrin Ott – RHM, Aerospace Operational Medicine Core Technical Competency Lead

    • Dr. (Mark) Tyler Nelson – RHB, Organ on a Chip Team Lead

    • Dr. Jeffery Gearhart – RHM, Biological Modeling Team Lead

    • Dr. Patrick McLendon – RHM, In Vitro Modeling Team Lead

    • Dr. Anne Bang – Sanford Burnham Prebys

    • Dr. Joseph Jarvis – RHB, Bioinformatics Team Lead

  • Cleared, 88PA, Case # 201x-xxxx, xx Mon 201x.20

    Questions?

    Air Force 711th Human Performance Wing – Application of NAMsTotal Exposure Health – Big PictureSystems Biology for Performance VisionIn Vitro to In Vivo ExtrapolationIn Vitro Data ProductionIn Vitro – human stem cellsAirman-on-a-Chip: Gut-Microbiome-Brain Axis Work-Flow Gut-Organ Axis Discovery/Evaluation�Modeling Performance Enhancement/Protection-tDCS Using Human Mini BrainsIn Vitro – Personalized RiskAssessment of Neuro-Vascular Responses to Hyperoxic Oscillations in Airman: A Systems Biology ApproachBiological Systems ModelingDevelopment of a Generalized Inhalation Model for Use with the High-Throughput Toxicokinetics (httk) Package in RThe Potential for Genetic Variation to Impact Risk Estimates from Chemical Exposures in a United States Air Force PopulationDevelopment of Exposure Limits for Chemicals �Encountered During Aircraft OperationIn Vivo ValidationIn Vivo ValidationSummaryAcknowledgementsQuestions?